Quarterly figures: Box office hit Jardiance and US business drive Boehringer Ingelheim

—·3h

The pharmaceutical company Boehringer Ingelheim's sales grew in the first half of the year. The decisive factors are the US market and a diabetes drug.

TickersUSChannelssemiconductors, stocksCountriesgermany, europe, ukCategoriespharma

Open original source ↗

Published

7/15/2026, 8:19:09 AM

Fetched

7/15/2026, 9:07:58 AM

Confidence

60 / 100

Relevance

35 / 100

Trust

—

Language